Stock Rating Downgrade
The Value Trend Rating for Resmed Inc (NYSE: RMD) weakened in recent days from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Resmed Inc (NYSE: RMD) stock enjoyed a large increase of 3.3% on 3/7/25. The stock closed at $232.44. Trading volume in this advance was normal. The stock has been strong relative to the market over the last nine months and has risen 0.5% during the last week.
Current PriceTarget Research Rating
Resmed has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Resmed has a poor Appreciation Score of 16 but a slightly positive Power Rating of 63, triggering the Negative Value Trend Rating.
Be the first to comment